03:02 AM EDT, 08/21/2026 (MT Newswires) -- DSM-Firmenich (DSFIR.AS, DSFIR.SW) said Friday it launched patent infringement proceedings in China against several Chinese entities over the alleged unauthorized use of its technology for producing sclareol. The nutrition, health, and beauty company filed the case with the Xiong'An New District Court in China's Hebei Province against defendants including a sclareol producer and a research institute. It is seeking to halt the alleged infringement and receive compensation. Sclareol is used as an intermediate in the production of amber fragrance ingredients, including Ambrox Super.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.